Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- Check3 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new iteration of the page content. It represents a minor update to the page rendering and does not change the information shown.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's versioning information.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a newer template/version update without changing the study data.SummaryDifference0.0%

- Check47 days agoChange DetectedThe MOSAIC study page now indicates that recruitment is closed. It also adds user-guidance sections to help readers understand the study record and how to join.SummaryDifference0.5%

- Check54 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page. No study data, eligibility criteria, or results were altered.SummaryDifference0.0%

- Check75 days agoChange DetectedA new software revision, v3.5.4, was added and the previous revision, v3.5.3, was removed. This indicates an update to the site's underlying platform, likely including fixes or minor enhancements.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.